Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Can Voluntary Third Party Inspections Cure FDA’s Inspection Woes?

This article was originally published in The Gray Sheet

Executive Summary

FDA's third party 510(k) review program provides a successful model for the agency to pattern third party inspections, National Electrical Manufacturers Association VP Robert Britain told the HHS Secretary's Advisory Committee on Regulatory Reform at its inaugural meeting in Washington, DC

You may also be interested in...



Tauzin Will Tackle Device Reforms Outside PDUFA; Eshoo Urges Hearings

House Energy & Commerce Committee Chairman Billy Tauzin (R-La.) will work with medical device reform bill sponsors to move HR 3580 independently of Prescription Drug User Fee Act reauthorization

Tauzin Will Tackle Device Reforms Outside PDUFA; Eshoo Urges Hearings

House Energy & Commerce Committee Chairman Billy Tauzin (R-La.) will work with medical device reform bill sponsors to move HR 3580 independently of Prescription Drug User Fee Act reauthorization

State Device Inspection Contracts Expected To Be Signed By Summer

Health department personnel in as many as 11 states and Puerto Rico could begin conducting medical device facility inspections for FDA by early summer under an initiative designed to bolster the agency's shrinking field resources

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015927

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel